Free Republic 3rd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $54,503
67%  
Woo hoo!! And we're now over 67%!! Thank you all very much!! God bless.

Keyword: tricor

Brevity: Headers | « Text »
  • This common drug might save people with COVID-19

    01/16/2021 7:10:30 PM PST · by blueplum · 62 replies
    BGR ^ | 15 Jan 2021 | Yoni Heisler
    A new research study finds that the drug Fenofibrate — which is used to help keep cholesterol levels low — can potentially help treat patients suffering from the coronavirus. The study, which was recently highlighted by Knowridge, relays that the coronavirus typically impacts the body’s ability to burn carbohydrates. This, in turn, causes “large amounts of fat to accumulate inside lung cells, a condition the virus needs in order to reproduce.”... ...One of the study’s authors, Professor Yaakov Nahmias, adds: We showed that the human lungs responded to the SARS-CoV-2 virus by completely changing their metabolism, causing a major buildup...
  • Cholesterol-lowering meds have potential to downgrade COVID-19's threat to that of the common cold

    07/27/2020 4:33:02 PM PDT · by absalom01 · 55 replies
    Medicalxpress ^ | JULY 15, 2020 | Hebrew University of Jerusalem
    Could a simple drug that has been on the market for decades be used to treat COVID-19? A research team led by Hebrew University of Jerusalem (HU)'s Professor Yaakov Nahmias says that early research looks promising; their findings appear in this week's Cell Press Sneak Peak. Over the last three months, Nahmias and Dr. Benjamin tenOever at New York's Icahn School of Medicine at Mount Sinai have focused on the ways in which the SARS-CoV-2 changes patients' lungs in order to reproduce itself. Their major finding? This virus prevents the routine burning of carbohydrates. As a result, large amounts of...
  • Could new treatment massively reduce dangers of the coronavirus? [Tricor]

    07/15/2020 8:16:21 PM PDT · by Olog-hai · 16 replies
    INN ^ | 07/14/20 19:01 | Arutz Sheva Staff
    Could a simple drug, that has been on the market for decades, be used to treat COVID-19? A research team led by Hebrew University of Jerusalem (HU)’s Professor Yaakov Nahmias says that early research looks promising; their findings appear in this week’s Cell Press’ Sneak Peak. Over the last three-months, Nahmias and Dr. Benjamin tenOever at New York’s Mount Sinai Medical Center have focused on the ways in which the SARS-CoV-2 (AKA the coronavirus that’s causing our current pandemic) changes patients’ lungs in order to reproduce itself. Their major finding? This virus prevents the routine burning of carbohydrates. As a...